Carl Dambkowski

Insider Reports History

Entity
Individual
Location
221 Crescent St., Building 17, Suite 102 B, Waltham, MA
Signature
/s/ Matthew Batters, as attorney-in-fact for Carl Dambkowski
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carl Dambkowski:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apogee Therapeutics, Inc. Chief Medical Officer Common Stock 247K $9.29M $37.59 Apr 2, 2025 Direct
Apogee Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 171K Feb 5, 2025 Direct

Insider Reports Filed by Carl Dambkowski

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APGE Apogee Therapeutics, Inc. Apr 2, 2025 3 -$140K 4 Apr 4, 2025 Chief Medical Officer
APGE Apogee Therapeutics, Inc. Mar 5, 2025 1 -$48.5K 4 Mar 7, 2025 Chief Medical Officer
APGE Apogee Therapeutics, Inc. Feb 5, 2025 3 -$125K 4 Feb 7, 2025 Chief Medical Officer
APGE Apogee Therapeutics, Inc. Jan 2, 2025 5 -$161K 4 Jan 3, 2025 Chief Medical Officer
APGE Apogee Therapeutics, Inc. Dec 11, 2024 4 -$180K 4 Dec 13, 2024 Chief Medical Officer
APGE Apogee Therapeutics, Inc. Dec 9, 2024 1 $0 4 Dec 11, 2024 Chief Medical Officer
APGE Apogee Therapeutics, Inc. Dec 4, 2024 1 -$307K 4 Dec 6, 2024 Chief Medical Officer
APGE Apogee Therapeutics, Inc. Nov 6, 2024 2 -$394K 4 Nov 8, 2024 Chief Medical Officer
APGE Apogee Therapeutics, Inc. Oct 2, 2024 2 -$375K 4 Oct 4, 2024 Chief Medical Officer
APGE Apogee Therapeutics, Inc. Sep 4, 2024 2 -$317K 4 Sep 6, 2024 Chief Medical Officer
ORKA Oruka Therapeutics, Inc. Aug 29, 2024 0 $0 3 Sep 6, 2024 Director
APGE Apogee Therapeutics, Inc. Aug 7, 2024 3 -$298K 4 Aug 9, 2024 Chief Medical Officer
APGE Apogee Therapeutics, Inc. Jul 3, 2024 2 -$225K 4 Jul 5, 2024 Chief Medical Officer
APGE Apogee Therapeutics, Inc. Dec 18, 2023 1 $0 4 Dec 20, 2023 Chief Medical Officer
APGE Apogee Therapeutics, Inc. Jul 13, 2023 0 $0 3/A Jul 17, 2023 Chief Medical Officer